Prednisone-Induced Weight Gain

Introduction to Weight Gain

• The American College of Rheumatology suggests that prednisone causes weight gain in a dose-dependent manner, with approximately 20% of patients reporting weight gain at doses ≥5 mg/day compared to <10% at doses <5 mg/day, and the effect is most pronounced in the first 9 months of treatment 1, 2

Dose-Response Relationship

• The risk of weight gain increases significantly with higher cumulative doses, with approximately 22% of patients reporting weight gain at doses 5-7.5 mg/day 2, 3
• Cumulative doses >1.7 grams are associated with significantly increased odds of weight gain, with OR 1.42 (95% CI 1.08-1.85) at 1.7-2.8 grams, escalating to OR 2.20 (95% CI 1.65-2.95) at cumulative doses >4.7 grams 1, 2

Timeline of Weight Gain

• Weight gain occurs predominantly in the first 9 months after initiation and then plateaus, with multiple trials demonstrating that weight gain occurs early after glucocorticoid initiation 1, 2, 3
• Patients treated for ≤1 year had a mean weight increase of 2.7 kg, while those treated >1 year had lower mean weight at last visit compared to baseline 1, 2

Reversibility After Discontinuation

• Weight loss occurs after prednisone discontinuation, with one study showing patients who received 7.5 mg prednisolone for 2 years lost an average of 3.1 kg one year after discontinuation 1, 3, 4, 5

Clinical Impact and Quality of Life

• Over 40% of patients with rheumatoid arthritis consider weight gain the "most bothersome in everyday life" adverse effect attributed to glucocorticoids, more than other listed side effects 4, 5
• Obesity increases risk of type 2 diabetes, cancer, and cardiovascular disease, and weight gain negatively impacts body image and self-esteem 4, 5

Prevention Strategies

• The American College of Rheumatology recommends using the lowest effective dose, as weight gain risk increases substantially at doses ≥5 mg/day 1, 2
• Consider steroid-sparing agents early, particularly in pediatric patients where growth and bone development are concerns 6
• Monitor weight at baseline and regularly during treatment (>2 kg gain in a month or ≥7% increase from baseline warrants intervention) 7

Weight Gain Associated with Stable‑Dose Prednisone

Magnitude of Expected Weight Gain

• In randomized controlled trials, prednisone‑treated participants experienced a mean weight increase ranging from 0 kg to 5 kg over 1–2 years, whereas untreated controls showed changes from 0 kg to 3 kg. This dose‑related effect was observed across multiple study populations. Evidence level: high (randomized controlled trials). 8

Changes in Body Composition

• Among individuals with early rheumatoid arthritis receiving prednisolone, total body mass rose by approximately 1.6 kg and total fat mass by about 1.3 kg after 26 weeks of therapy. Evidence level: high (randomized controlled trial). 8

Clinical Guidance on Attribution of Weight Gain

• Attributing all weight gain solely to dietary excess, without acknowledging the metabolic effects of glucocorticoids (e.g., increased appetite, fluid retention, fat redistribution), can undermine patient trust and adherence to therapy. Evidence level: moderate (observational data within trial cohort). 8